ALLMedicine™ Apraxia Center
Research & Reviews 919 results
https://doi.org/10.1044/2022_JSLHR-22-00438
Journal of Speech, Language, and Hearing Research : JSLHR; Haley KL, Jacks A et. al.
Mar 15th, 2023 - During motor speech examinations for suspected apraxia of speech (AOS), clients are routinely asked to repeat words several times sequentially. The purpose of this study was to understand the task in terms of the relationship among consecutive att...
https://doi.org/10.1044/2022_AJSLP-21-00236
American Journal of Speech-language Pathology; Munasinghe TU, Ariyasena ADK et. al.
Mar 15th, 2023 - This systematic review aims to summarize and evaluate the available literature on speech and language therapy interventions for acquired apraxia of speech since 2012. A systematic search in six electronic databases was performed from 2013 to 2020....
https://clinicaltrials.gov/ct2/show/NCT04957225
Mar 9th, 2023 - According to the Swedish National Board of Health and Welfare's guidelines for stroke care, persons with aphasia shall be offered intensive rehabilitation by speech-language pathologists. The aphasia rehabilitation is however sparse and unevenly d...
https://doi.org/10.1111/ene.15766
European Journal of Neurology; García AM
Mar 8th, 2023 - In this issue of European Journal of Neurology, Robinson et al. present a novel study on primary progressive apraxia of speech. The authors describe different clinicopathological profiles in patients with left-dominant, right-dominant, and bilater...
http://emedicine.medscape.com/article/1154074-overview
Mar 7th, 2023 - Clues to Diagnosis Several primary neurodegenerative disorders distinct from Parkinson's disease (PD) share parkinsonian features of bradykinesia, rigidity, tremor, and balance disturbances. These disorders have complex clinical presentations that...
Drugs 1 results see all →
Clinicaltrials.gov 68 results
https://clinicaltrials.gov/ct2/show/NCT04957225
Mar 9th, 2023 - According to the Swedish National Board of Health and Welfare's guidelines for stroke care, persons with aphasia shall be offered intensive rehabilitation by speech-language pathologists. The aphasia rehabilitation is however sparse and unevenly d...
https://clinicaltrials.gov/ct2/show/NCT05185583
Feb 23rd, 2023 - This is a randomised, double-blind, placebo-controlled, two-period crossover proof-of-concept trial of methylphenidate (MPH) for children with childhood apraxia of speech (CAS). 24 children aged 6 to 12 years with CAS will be recruited. If childre...
https://clinicaltrials.gov/ct2/show/NCT03903120
Feb 16th, 2023 - This research involves a hypothesis-driven series of Phase 1 studies using comparative group designs to investigate a new integral stimulation treatment program for children with CAS, called ASSIST (Apraxia of Speech Systematic Integral Stimulatio...
https://clinicaltrials.gov/ct2/show/NCT05259176
Feb 15th, 2023 - Limbs apraxia is a motor disorder whose characteristic is the inability or difficulty to perform intentional movements of the limbs (gestures), most frequently involving the upper limbs. Recent literature indicated promising effects of transcrania...
https://clinicaltrials.gov/ct2/show/NCT03463902
Feb 14th, 2023 - Schizophrenia is associated with poor social functioning, which is perturbed by deficits in social interaction including nonverbal communication. The use of hand gestures is critical for nonverbal communication, but the majority of schizophrenia p...
News 15 results
https://www.onclive.com/view/biomarker-hunt-focuses-on-predicting-immunotherapy-adverse-events
Dec 5th, 2020 - Douglas B. Johnson, MD Findings from recent studies have begun to answer a question that oncologists have been asking since the FDA approved the first immune checkpoint inhibitor, ipilimumab (Yervoy), in 2011: Which patients will tolerate a parti...
https://www.medscape.com/viewarticle/899079
Jul 9th, 2018 - "Chasing the dragon" (CTD) — a method of inhaling heroin in which users heat heroin over aluminium foil with a lighter and then chase the fumes — is growing in popularity and may lead to "peculiar and often catastrophic brain complications," new r...
https://www.mdedge.com/neurology/article/136563/parkinsons-disease/can-botulinum-toxin-benefit-people-parkinsons-disease
Apr 25th, 2017 - Robert Chen, MBBChir MIAMI—Botulinum toxin may be a clinically useful treatment for motor and nonmotor manifestations of Parkinson’s disease and parkinsonism, according to an overview presented at the First Pan American Parkinson’s Disease and Mov.
https://www.medscape.com/viewarticle/875002
Jan 26th, 2017 - Two cases of what is suggested to be "the first recognised cases of severely exacerbated CNS [central nervous system] inflammation after alemtuzumab therapy in multiple sclerosis" have been published. Writing in a letter in the February issue of T...
https://www.mdedge.com/psychiatry/article/113800/alzheimers-cognition/experts-review-challenges-pearls-young-onset-dementia
Amy Karon
Sep 19th, 2016 - SAN FRANCISCO – The patient, a man in his early 50s, smiled as he sang about flatulence. He seemed alert, relaxed, and aware of his wife and the neurologist in the room.